However, with diabetes and augmentation of the availability of FAs, either through an increase in vascular LPL or adipose tissue lipolysis, the diabetic heart has a mismatch between delivery of FAs and their oxidation, leading to myocyte lipid droplet synthesis and the accumulation of lipid metabolites (e.g., DAG, LPC and ceramide). Here, LPL is linked to diabetes mellitus.